- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Medical Equipment/Devices
- Sub-Industry: Cardiovascular Devices
AngioDynamics Inc
+ Add to WatchlistANGO:US
11.0500 USD 0.1300 1.16%As of 17:20:00 ET on 06/19/2013.
Snapshot for AngioDynamics Inc (ANGO)
| Open: | 11.2100 | Day's Range: | 11.0300 - 11.2100 | Volume: | 17,100 |
|---|---|---|---|---|---|
| Previous Close: | 11.1800 | 52wk Range: | 9.5150 - 12.9100 | 1-Yr Rtn: | -10.31% |
Key Statistics for ANGO
| Current P/E Ratio (ttm) | 28.2468 |
|---|---|
| Estimated P/E(05/2013) | 32.2157 |
| Relative P/E vs. SPX | 1.7457 |
| Earnings Per Share (USD) (ttm) | 0.3912 |
| Est. EPS (USD) (05/2013) | 0.3430 |
| Est. PEG Ratio | 2.1477 |
| Market Cap (M USD) | 387.30 |
| Shares Outstanding (M) | 35.05 |
| 30 Day Average Volume | 61,826 |
| Price/Book (mrq) | 0.7342 |
| Price/Sale (ttm) | 1.1698 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/12/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ANGO
Company Profile & Key Executives for ANGO
AngioDynamics, Inc. designs, develops, manufactures, and markets therapeutic and diagnostic devices. The Company's products enable interventional physicians to treat peripheral vascular disease and other non-coronary diseases. AngioDynamic's product lines consist of angiographic catheters, hemodialysis catheters, image guided vascular access products, and thrombolytic products.
| Joseph M Devivo "Joe"President/CEO | Mark T FrostExec VP/CFO |
| Stephen J McGillSenior VP/Gen Mgr:Intl | Alan PanzerSenior VP/General Manager:US Sales |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ANGO News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page